Serum Inflammatory Biomarkers in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy.
: Monocyte-to-lymphocyte ratio
Neutrophil-to-lymphocyte ratio
Non-arteritic ischemic optic neuropathy
Platelet-to-lymphocyte ratio
Systemic immune-inflammation index
Journal
Korean journal of ophthalmology : KJO
ISSN: 2092-9382
Titre abrégé: Korean J Ophthalmol
Pays: Korea (South)
ID NLM: 8804513
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
27
05
2020
accepted:
20
10
2020
entrez:
14
12
2020
pubmed:
15
12
2020
medline:
26
11
2021
Statut:
ppublish
Résumé
To evaluate the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) in patients with non-arteritic anterior ischemic optic neuropathy (NAION). Fifty-six patients with NAION and 60 age-sex matched healthy controls were included in the study. Demographic characteristics and laboratory findings of the patients and the controls were obtained from the electronic medical records. NLR, PLR, MLR, and SII were calculated and compared between the groups. Cutoff values were also determined. Neutrophil, monocyte and platelet counts were higher in the NAION group than in the control group, but the difference was not statistically significant (p > 0.05). The mean NLR and SII were higher in the NAION group than in the control group (p = 0.004 and p = 0.011, respectively). In the receiver operating characteristic curve analysis, the areas under the curve for NLR were 0.67, and NLR >1.79 predicted NAION with a sensitivity of 71% and specificity of 59%. The areas under the curve for SII was 0.66, and SII of >417 predicted NAION with a sensitivity of 71% and specificity of 49%. There was no significant difference in PLR and MLR between the groups (p = 0.105 and p = 0.347, respectively). The current study demonstrated that NAION patients had increased NLR and SII levels compared with control subjects. Elevated NLR and SII might serve as readily available inflammatory predictors in NAION patients.
Identifiants
pubmed: 33307608
pii: kjo.2020.0075
doi: 10.3341/kjo.2020.0075
pmc: PMC7738228
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
478-484Références
J Neuroophthalmol. 1994 Mar;14(1):38-44
pubmed: 8032479
J Glaucoma. 2016 Oct;25(10):e815-e820
pubmed: 26918914
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S127-S131
pubmed: 28017281
Neuroimmunomodulation. 2016;23(2):67-74
pubmed: 26926300
Eur J Ophthalmol. 2015 Jul-Aug;25(4):343-6
pubmed: 25633622
Clin Cancer Res. 2014 Dec 1;20(23):6212-22
pubmed: 25271081
Clin Exp Optom. 2020 Jul;103(4):490-494
pubmed: 31773807
Prog Retin Eye Res. 2009 Jan;28(1):34-62
pubmed: 19063989
Neuroophthalmology. 2018 Jan 9;42(5):287-294
pubmed: 30258474
Graefes Arch Clin Exp Ophthalmol. 2016 Jul;254(7):1345-51
pubmed: 27118038
Indian J Ophthalmol. 2000 Sep;48(3):171-94
pubmed: 11217249
Am J Ophthalmol. 1994 Dec 15;118(6):766-80
pubmed: 7977604
Am J Cardiol. 2010 Aug 15;106(4):470-6
pubmed: 20691303
J Neuroophthalmol. 2005 Mar;25(1):22-4
pubmed: 15756128
J Hypertens. 2002 May;20(5):851-7
pubmed: 12011644
J Neuroophthalmol. 2003 Jun;23(2):157-63
pubmed: 12782932
Balkan Med J. 2015 Oct;32(4):382-7
pubmed: 26740898
J Am Coll Cardiol. 2012 Oct 16;60(16):1512-20
pubmed: 22999728
Cancer Cell. 2013 Jul 8;24(1):130-7
pubmed: 23810565
Oncotarget. 2017 Mar 25;8(40):68984-68995
pubmed: 28978173
J Cardiovasc Pharmacol Ther. 2014 Mar;19(2):170-8
pubmed: 24177335
Am J Cardiol. 2010 Jul 1;106(1):56-61
pubmed: 20609648
J Cancer. 2018 Sep 7;9(18):3295-3302
pubmed: 30271489
Clin Rheumatol. 2017 Dec;36(12):2689-2695
pubmed: 28913574
Rev Diabet Stud. 2007 Summer;4(2):98-104
pubmed: 17823694
Medicine (Baltimore). 2016 Apr;95(14):e3248
pubmed: 27057867
Hamostaseologie. 2016;36(1):46-54
pubmed: 26778257
Arch Ophthalmol. 2011 Dec;129(12):1583-91
pubmed: 22159678
Int J Cancer. 2020 Feb 1;146(3):692-698
pubmed: 30924141
Ocul Immunol Inflamm. 2015 Aug;23(4):287-290
pubmed: 24987927
Prog Retin Eye Res. 2011 May;30(3):167-87
pubmed: 21376134
Curr Pharm Des. 2018;24(3):281-290
pubmed: 29318966
Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):1873-84
pubmed: 23821118
Korean J Ophthalmol. 2017 Apr;31(2):159-164
pubmed: 28367045